Antibody-dependent cellular cytotoxicity [ADCC]

Industry

CPC
C07K2317/732

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K2317/00Immunoglobulins specific feautures

Current Industry

C07K2317/732Antibody-dependent cellular cytotoxicity [ADCC]

Industries

Patents Grantslast 30 patents

Information Patent Grant
Soluble universal ADCC-enhancing synthetic fusion gene and peptide...
- Patent number 12,247,062
- Issue date Mar 11, 2025
- 1GLOBE BIOMEDICAL CO., LTD.
- Chiang J. Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Markers selectively deregulated in tumor-infiltrating regulatory T...
- Patent number 12,247,982
- Issue date Mar 11, 2025
- CheckMab S.R.L.
- Sergio Abrignani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-CTLA-4 antibodies and methods of use thereof
- Patent number 12,246,066
- Issue date Mar 11, 2025
- Agenus Inc.
- Marc van Dijk
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal anti-IL-1RAcP antibodies
- Patent number 12,240,898
- Issue date Mar 4, 2025
- SANOFI BIOTECHNOLOGY
- Stephan Fischer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies binding CTLA-4 and uses thereof
- Patent number 12,240,905
- Issue date Mar 4, 2025
- HARBOUR BIOMED (SHANGHAI) CO., LTD.
- Xin Gan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-C-C motif chemokine receptor 8 (CCR8) antibodies and methods o...
- Patent number 12,240,910
- Issue date Mar 4, 2025
- Genentech, Inc.
- Gautham Gampa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides encoding antibodies which bind the EC3 domain of ca...
- Patent number 12,233,155
- Issue date Feb 25, 2025
- Daiichi Sankyo Company, Limited
- Atsuko Saito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-Siglec-7 antibodies and methods of use thereof
- Patent number 12,227,568
- Issue date Feb 18, 2025
- ALECTOR LLC
- Patricia Culp
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies with increased stability
- Patent number 12,227,569
- Issue date Feb 18, 2025
- Innate Pharma
- Laurent Gauthier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD3 constructs and uses thereof
- Patent number 12,227,574
- Issue date Feb 18, 2025
- AMBERSTONE BIOSCIENCES, INC.
- Yonglei Shang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized monoclonal advanced glycation end-product antibody
- Patent number 12,226,465
- Issue date Feb 18, 2025
- Siwa Corporation
- Lewis S. Gruber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CHIKV antibodies and uses thereof
- Patent number 12,227,560
- Issue date Feb 18, 2025
- Sanofi
- Kara Carter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CEACAM6 antibodies and methods of use
- Patent number 12,227,570
- Issue date Feb 18, 2025
- Singapore Health Services Pte Ltd.
- Hau Wan Leung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-SIRP-alpha antibodies and methods of use thereof
- Patent number 12,226,482
- Issue date Feb 18, 2025
- ALECTOR LLC
- Andrew Pincetic
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Caninized human antibodies to human IL-4R alpha
- Patent number 12,221,486
- Issue date Feb 11, 2025
- INTERVET INC.
- Mohamad Morsey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies to human B7x for treatment of metastatic cancer
- Patent number 12,221,489
- Issue date Feb 11, 2025
- Albert Einstein College of Medicine
- Xingxing Zang
- G01 - MEASURING TESTING
Information Patent Grant
Antibody variants
- Patent number 12,215,146
- Issue date Feb 4, 2025
- TILLOTTS PHARMA AG
- Esther Maria Furrer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BAFF-R targeted chimeric antigen receptor-modified T-cells and uses...
- Patent number 12,215,162
- Issue date Feb 4, 2025
- City of Hope
- Hong Qin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Humanized anti-human CD19 antibodies and methods of use
- Patent number 12,215,152
- Issue date Feb 4, 2025
- HOFFMANN-LA ROCHE INC.
- Claudia Ferrara Koller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen binding constructs targeting HER2
- Patent number 12,215,166
- Issue date Feb 4, 2025
- ZYMEWORKS BC INC.
- Nina E. Weisser
- G01 - MEASURING TESTING
Information Patent Grant
Anti-Met fab-Fc for the treatment of a tumor and/or metastasis
- Patent number 12,209,129
- Issue date Jan 28, 2025
- PIERRE FABRE MEDICAMENT
- Elisa Vigna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD38 antibodies
- Patent number 12,209,138
- Issue date Jan 28, 2025
- Takeda Pharmaceutical Company Limited
- Kathleen Ann Elias
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-TIM-3 antibodies
- Patent number 12,202,894
- Issue date Jan 21, 2025
- WuXi Biologics Ireland Limited
- Siwei Nie
- G01 - MEASURING TESTING
Information Patent Grant
Compositions including a therapeutic antibodies and/or a checkpoint...
- Patent number 12,201,686
- Issue date Jan 21, 2025
- 7 Hills Pharma Inc.
- Darren G. Woodside
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibody that specifically binds to CD20
- Patent number 12,202,906
- Issue date Jan 21, 2025
- Pavel Andreevich Iakovlev
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-FLT3 antigen binding proteins
- Patent number 12,195,543
- Issue date Jan 14, 2025
- Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
- Gundram Jung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to VISTA at acidic pH
- Patent number 12,195,535
- Issue date Jan 14, 2025
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine...
- Patent number 12,195,551
- Issue date Jan 14, 2025
- Merus N.V.
- David Andre Baptiste Maussang-Detaille
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual specificity antibodies to PD-L1 and PD-L2 and methods of use t...
- Patent number 12,187,799
- Issue date Jan 7, 2025
- Board of Regents, The University of Texas System
- Michael A. Curran
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
NK cells with an increased antibody-dependent cellular toxicity (AD...
- Patent number 12,188,005
- Issue date Jan 7, 2025
- The United States of America, as represented by the Secretary, Department of...
- Richard W. Childs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
PROCESS FOR PRODUCING PERSONALIZED CANCER IMMUNOTHERAPY
- Publication number 20250073323
- Publication date Mar 6, 2025
- ANYADI, LLC
- Marc Andrew GILLIG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC BINDING PROTEINS AND USES THEREOF
- Publication number 20250074986
- Publication date Mar 6, 2025
- Medimmune, LLC
- SRINATH KASTURIRANGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUC1 and CD16A Antibodies and Methods of Use
- Publication number 20250075002
- Publication date Mar 6, 2025
- BEIGENE SWITZERLAND GMBH
- Hui LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF
- Publication number 20250066487
- Publication date Feb 27, 2025
- ABL Bio Inc.
- Yeryoung Yong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TIGIT ANTIBODIES AND USE THEREOF
- Publication number 20250064909
- Publication date Feb 27, 2025
- MediMabBio Inc.
- Yuhoi KANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF
- Publication number 20250066489
- Publication date Feb 27, 2025
- MERSANA THERAPEUTICS, INC.
- Natalya D. BODYAK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS
- Publication number 20250066473
- Publication date Feb 27, 2025
- The Board of Trustees of the Leland Stanford Junior University
- Stephen Willingham
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FC VARIANT COMPOSITIONS AND METHODS OF USE THEREOF
- Publication number 20250066481
- Publication date Feb 27, 2025
- Dana-Farber Cancer Institute, Inc.
- Wayne A. Marasco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST HER2
- Publication number 20250066506
- Publication date Feb 27, 2025
- GENMAB A/S
- Bart DE GOEIJ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING
- Publication number 20250066497
- Publication date Feb 27, 2025
- Genzyme Corporation
- Clark PAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF
- Publication number 20250059256
- Publication date Feb 20, 2025
- Ohio State Innovation Foundation
- Pravin T.P. KAUMAYA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-FRa ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF
- Publication number 20250059274
- Publication date Feb 20, 2025
- Bio-Thera Solutions, Ltd.
- Weijia TANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOTOXICITY TARGETING CHIMERAS FOR PROSTATE SPECIFIC MEMBRANE ANTI...
- Publication number 20250057827
- Publication date Feb 20, 2025
- GlaxoSmithKline Intellectual Property Development Limited
- Christina Ng Di Marco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS COMPOSED OF AN ANTIBODY AND A MUTEIN
- Publication number 20250049890
- Publication date Feb 13, 2025
- CENTRO DE INMUNOLOGIA MOLECULAR
- Ana Victoria CASADESÚS PAZOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EPHA2 ANTIBODIES
- Publication number 20250051464
- Publication date Feb 13, 2025
- Immunome, Inc.
- Alexander Scholz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBO...
- Publication number 20250051469
- Publication date Feb 13, 2025
- The General Hospital Corporation
- Denise L. Faustman
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOTOXICITY TARGETING CHIMERAS FOR CXCR3-EXPRESSING CELLS
- Publication number 20250051479
- Publication date Feb 13, 2025
- GlaxoSmithKline Intellectual Property Development Limited
- Brandon James Turunen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-TSLP ANTIBODIES
- Publication number 20250051433
- Publication date Feb 13, 2025
- INMAGENE PTE. LTD.
- Run LEI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DEPLETION OF NK CELLS FOR THE TREATMENT OF ADVERSE POST-ISCHEMIC CA...
- Publication number 20250051440
- Publication date Feb 13, 2025
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Hafid AIT-OUFELLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A NOVEL METHOD OF TREATING TARGETED ABNORMAL CELLS, AND CYTOTOXIC C...
- Publication number 20250041340
- Publication date Feb 6, 2025
- Acepodia Biotechnologies Ltd.
- CHING-WEN HSIAO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DLK1 ANTIBODIES AND METHODS OF TREATING CANCER
- Publication number 20250042992
- Publication date Feb 6, 2025
- The Regents of the University of California
- Dennis Slamon
- G01 - MEASURING TESTING
Information Patent Application
SIGLEC-8 BINDING PROTEINS AND USES THEREOF
- Publication number 20250042997
- Publication date Feb 6, 2025
- Phylaxis Bioscience, LLC
- Tony Dung-Ling Yao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY VARIANTS AND USES THEREOF
- Publication number 20250043018
- Publication date Feb 6, 2025
- Paul PARREN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND MATERIALS FOR TREATING CANCER
- Publication number 20250041421
- Publication date Feb 6, 2025
- SHANGHAI MIRACOGEN INC
- Chaohong HU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-GPRC5D ANTIBODIES AND COMPOSITIONS
- Publication number 20250042993
- Publication date Feb 6, 2025
- SANOFI
- Elisabeth REMY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES
- Publication number 20250034270
- Publication date Jan 30, 2025
- Novartis AG
- Christoph HUESSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF
- Publication number 20250032633
- Publication date Jan 30, 2025
- SHANGHAI MIRACOGEN INC
- Chaohong HU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES AGAINST C-KIT
- Publication number 20250034246
- Publication date Jan 30, 2025
- Forty Seven, Inc.
- Jie Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DUAL TARGETING OF PEDIATRIC MALIGNANCIES THROUGH CAR T-CELLS SECRET...
- Publication number 20250032543
- Publication date Jan 30, 2025
- The Children's Hospital of Philadelphia
- Kristopher R. BOSSE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SIGLEC-8 ANTIBODIES AND USES THEREOF
- Publication number 20250034245
- Publication date Jan 30, 2025
- Fred Hutchinson Cancer Center
- Roland B. Walter
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Antibody-dependent cellular cytotoxicity [ADCC]

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Soluble universal ADCC-enhancing synthetic fusion gene and peptide...

Markers selectively deregulated in tumor-infiltrating regulatory T...

Anti-CTLA-4 antibodies and methods of use thereof

Monoclonal anti-IL-1RAcP antibodies

Antibodies binding CTLA-4 and uses thereof

Anti-C-C motif chemokine receptor 8 (CCR8) antibodies and methods o...

Polynucleotides encoding antibodies which bind the EC3 domain of ca...

Anti-Siglec-7 antibodies and methods of use thereof

Humanized antibodies with increased stability

Anti-CD3 constructs and uses thereof

Humanized monoclonal advanced glycation end-product antibody

Anti-CHIKV antibodies and uses thereof

Anti-CEACAM6 antibodies and methods of use

Anti-SIRP-alpha antibodies and methods of use thereof

Caninized human antibodies to human IL-4R alpha

Antibodies to human B7x for treatment of metastatic cancer

Antibody variants

BAFF-R targeted chimeric antigen receptor-modified T-cells and uses...

Humanized anti-human CD19 antibodies and methods of use

Bispecific antigen binding constructs targeting HER2

Anti-Met fab-Fc for the treatment of a tumor and/or metastasis

Anti-CD38 antibodies

Anti-TIM-3 antibodies

Compositions including a therapeutic antibodies and/or a checkpoint...

Monoclonal antibody that specifically binds to CD20

Anti-FLT3 antigen binding proteins

Antibodies binding to VISTA at acidic pH

Combination of an ErbB-2/ErbB-3 bispecific antibody with endocrine...

Dual specificity antibodies to PD-L1 and PD-L2 and methods of use t...

NK cells with an increased antibody-dependent cellular toxicity (AD...

Patents Applicationslast 30 patents

PROCESS FOR PRODUCING PERSONALIZED CANCER IMMUNOTHERAPY

BISPECIFIC BINDING PROTEINS AND USES THEREOF

MUC1 and CD16A Antibodies and Methods of Use

ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF

ANTI-TIGIT ANTIBODIES AND USE THEREOF

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

TREATMENT OF CANCER WITH COMBINATIONS OF IMMUNOREGULATORY AGENTS

FC VARIANT COMPOSITIONS AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODIES AGAINST HER2

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

ANTI-FRa ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

CYTOTOXICITY TARGETING CHIMERAS FOR PROSTATE SPECIFIC MEMBRANE ANTI...

FUSION PROTEINS COMPOSED OF AN ANTIBODY AND A MUTEIN

EPHA2 ANTIBODIES

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBO...

CYTOTOXICITY TARGETING CHIMERAS FOR CXCR3-EXPRESSING CELLS

NOVEL ANTI-TSLP ANTIBODIES

DEPLETION OF NK CELLS FOR THE TREATMENT OF ADVERSE POST-ISCHEMIC CA...

A NOVEL METHOD OF TREATING TARGETED ABNORMAL CELLS, AND CYTOTOXIC C...

DLK1 ANTIBODIES AND METHODS OF TREATING CANCER

SIGLEC-8 BINDING PROTEINS AND USES THEREOF

ANTIBODY VARIANTS AND USES THEREOF

METHODS AND MATERIALS FOR TREATING CANCER

ANTI-GPRC5D ANTIBODIES AND COMPOSITIONS

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF

HUMANIZED ANTIBODIES AGAINST C-KIT

DUAL TARGETING OF PEDIATRIC MALIGNANCIES THROUGH CAR T-CELLS SECRET...

SIGLEC-8 ANTIBODIES AND USES THEREOF